BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Scavilla confirmed the acquisition of Nevro Corporation for $250 million, expanding Globus Medical's reach into the musculoskeletal market, particularly in neuromodulation technology and chronic ...

Looking ahead to 2025, Globus Medical has provided guidance that reflects both its standalone operations and the impact of its recent acquisition of Nevro Corp (NYSE:NVRO). The company expects net ...

Additionally, the analyst acknowledged that the performance of Nevro and Emerging Technologies could provide some support to Globus Medical’s Spine business. However, there is a belief that even ...

Nevro technology has potential beyond its ... With no further questions, that concludes the Globus Medical’s earning call. Thank you for participating. You may now disconnect.

Two office buildings in Collegeville have sold to Audubon-based Globus Medical for $6.2 million, marking an 81 percent drop ...

The acquisition of Nevro Corporation is seen as a strategic move to expand into a $3 billion market space, enhancing Globus Medical Inc (NYSE:GMED)'s reach in the musculoskeletal market.

Globus Medical reported its financial results for Q1 2025 ... including launching innovative products and acquiring Nevro to expand into the neuromodulation market. Despite these efforts, supply chain ...

About Globus Medical, Inc. Globus Medical ... the risks and costs associated with the integration of the NuVasive and Nevro businesses and our ability to successfully integrate and achieve anticipated ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

Joining today's call from Globus Medical will be Dan Scavilla ... In April, we completed the purchase of all shares of the Nevro Corporation for an all-cash transaction of $250 million. The ...